These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8180725)

  • 1. Hypocaloric diet and antihypertensive drug treatment. A randomized controlled clinical trial.
    Darné B; Nivarong M; Tugayé A; Safar M; Plouin PF; Guillanneuf MT; Cubeau J; Pannier B; Péquignot F; Cambien F
    Blood Press; 1993 Jun; 2(2):130-5. PubMed ID: 8180725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orlistat in hypertensive overweight/obese patients: results of a randomized clinical trial.
    Bloch KV; Salles GF; Muxfeldt ES; Da Rocha Nogueira A
    J Hypertens; 2003 Nov; 21(11):2159-65. PubMed ID: 14597860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension.
    Manyemba J
    Cent Afr J Med; 1997 Dec; 43(12):344-9. PubMed ID: 9631111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial.
    Burke V; Beilin LJ; Cutt HE; Mansour J; Wilson A; Mori TA
    J Hypertens; 2005 Jun; 23(6):1241-9. PubMed ID: 15894901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study.
    Obara T; Ohkubo T; Funahashi J; Kikuya M; Asayama K; Metoki H; Oikawa T; Hashimoto J; Totsune K; Imai Y
    J Hypertens; 2005 Sep; 23(9):1653-60. PubMed ID: 16093909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure effects of antihypertensive drugs and changes in lifestyle in a Brazilian hypertensive cohort.
    Fuchs FD; Gus M; Moreira WD; Moreira LB; Moraes RS; Rosito GA; Sorucco A; Atanázio P; Machado R
    J Hypertens; 1997 Jul; 15(7):783-92. PubMed ID: 9222947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R; Marx A; Haller H
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.
    Jordan J; Engeli S; Boschmann M; Weidinger G; Luft FC; Sharma AM; Kreuzberg U
    J Hypertens; 2005 Dec; 23(12):2313-8. PubMed ID: 16269974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
    J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
    Chrysant SG; Chavanu KJ; Xu J
    Am J Cardiovasc Drugs; 2009; 9(4):241-51. PubMed ID: 19655819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
    Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM;
    J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension.
    Sellin L; Stegbauer J; Laeis P; Rump LC
    J Hypertens; 2005 Nov; 23(11):2083-92. PubMed ID: 16208152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Mancia G; Kjeldsen SE; Zappe DH; Holzhauer B; Hua TA; Zanchetti A; Julius S; Weber MA
    Eur Heart J; 2016 Mar; 37(12):955-64. PubMed ID: 26590384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of some parameters on the blood pressure reduction under treatment: experience from the Hypertension Optimal Treatment Study].
    Mallion JM; Baguet JP; Siché JP; Benkritly A
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1049-53. PubMed ID: 9749163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.